Disseminated on behalf of Onco-Innovations Ltd., may include paid advertisements. Investment Considerations Onco-Innovations is developing ONC010™, a nanoparticle-encapsulated PNKP inhibitor designed to target DNA repair pathways involved in cancer survival and treatment resistance. The company is positioning itself as a leader in the emerging PNKP inhibitor class, a segment of the broader DNA Damage Response … Continue reading “Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF)”
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |